Systemic therapy for metastatic renal cel... [Urol Clin North Am. 2008] - PubMed

loading

Review Targeted therapy for metastatic renal cell carcinoma. [J Clin Oncol. 2006]
Review Targeted therapy for metastatic renal cell carcinoma.
Motzer RJ, Bukowski RM. J Clin Oncol. 2006 Dec 10; 24(35):5601-8.
Review Sunitinib, sorafenib and mTOR inhibitors in renal cancer. [J BUON. 2007]
Review Sunitinib, sorafenib and mTOR inhibitors in renal cancer.
Radulovic S, Bjelogrlic SK. J BUON. 2007 Sep; 12 Suppl 1:S151-62.
Review New therapeutic approaches in the management of metastatic renal cell carcinoma. [J BUON. 2009]
Review New therapeutic approaches in the management of metastatic renal cell carcinoma.
Gkialas IK, Papadopoulos G. J BUON. 2009 Jul-Sep; 14(3):399-404.
Review Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnel. [Expert Rev Anticancer Ther. 2006]
Review Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnel.
Pouessel D, Culine S. Expert Rev Anticancer Ther. 2006 Dec; 6(12):1761-7.
Signaling inhibitors in metastatic renal cell carcinoma. [Cancer J. 2008]
Signaling inhibitors in metastatic renal cell carcinoma.
Escudier B. Cancer J. 2008 Sep-Oct; 14(5):325-9.

Fatigue in renal cell carcinoma: the hidden burden of current targeted therapies. [Oncologist. 2010]
Fatigue in renal cell carcinoma: the hidden burden of current targeted therapies.
Larkin JM, Pyle LM, Gore ME. Oncologist. 2010; 15(11):1135-46. Epub 2010 Nov 4.
Review Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapy. [Drug Resist Updat. 2009]
Review Synergistic combinations of signaling pathway inhibitors: mechanisms for improved cancer therapy.
Dent P, Curiel DT, Fisher PB, Grant S. Drug Resist Updat. 2009 Jun; 12(3):65-73. Epub 2009 Apr 22.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Systemic therapy for metastatic renal cell carcinoma.
Systemic therapy for metastatic renal cell carcinoma.
Urol Clin North Am. 2008 Nov ;35(4):687-701; ix.

PubMed
Human ADP-ribosylation factors. A functionally conserved family of GTP-binding p...
Human ADP-ribosylation factors. A functionally conserved family of GTP-binding proteins.
J Biol Chem. 1991 Feb 5 ;266(4):2606-14.

PubMed
Causality and gastrointestinal infections: Koch, Hill, and Crohn's.
Causality and gastrointestinal infections: Koch, Hill, and Crohn's.
Lancet Infect Dis. 2008 Nov ;8(11):720-6.

PubMed
Drug discovery: new models for industry-academic partnerships.
Drug discovery: new models for industry-academic partnerships.
Drug Discov Today. 2009 Jan ;14(1-2):95-101. Epub 2008 Nov 21 .

PubMed
In vitro profiling of the endocrine disrupting potency of organochlorine pestici...
In vitro profiling of the endocrine disrupting potency of organochlorine pesticides.
Toxicol Lett. 2008 Dec 15 ;183(1-3):65-71. Epub 2008 Oct 17 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed